Snowball logo
logo
BIS

ProShares UltraShort Nasdaq Biotechnology

BIS NASDAQ
$12.07-$0.23  (1.87%)
Dividends
Div. yield, TTM
6.54%
Annual payout, TTM
$0.79
Div.growth, 5y
3.66%
About the company
Ticker
BIS
ISIN
US74347G8380
Country
Other
Sector (GICS)
Other
The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the Daily Target. The index is designed to measure the performance of a set of Nasdaq-listed biotechnology and pharmaceutical companies. Under normal circumstances, the fund will obtain inverse leveraged exposure to at least 80% of its total assets in components of the index or in instruments with similar economic characteristics. The fund is non-diversified.

Frequently asked questions

What is the ProShares UltraShort Nasdaq Biotechnology (BIS) expense ratio?

The ProShares UltraShort Nasdaq Biotechnology funds expense ratio is 0.95%.

What is ProShares UltraShort Nasdaq Biotechnology (BIS) current stock price?

As of the latest data, ProShares UltraShort Nasdaq Biotechnology stock price is $12.07, with a previous close of $12.30. ProShares UltraShort Nasdaq Biotechnology lost -$0.23 in the last trading session, representing a -1.87% loss.

Does ProShares UltraShort Nasdaq Biotechnology (BIS) pay dividends?

Yes. ProShares UltraShort Nasdaq Biotechnology pays quarterly dividends with an annualized yield of 6.54% and an estimated annual payout of $0.79 per share.